Certain Reduced Folate Nutraceutical Products and L-Methylfolate Raw Ingredients Used Therein; Institution of Investigation Pursuant to United States Code, 63336-63337 [2012-25378]
Download as PDF
<![CDATA[
63336
Federal Register / Vol. 77, No. 200 / Tuesday, October 16, 2012 / Notices
duties, including whether the
information is useful; (b) evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information; (c) enhance the quality,
usefulness, and clarity of the
information that ONRR collects; and (d)
minimize the burden on the
respondents, including the use of
automated collection techniques or
other forms of information technology.
To comply with the public
consultation process, we published a
notice in the Federal Register on April
2, 2012 (77 FR 19704), announcing that
we would submit this ICR to OMB for
approval. The notice provided the
required 60-day comment period. We
received no unsolicited comments in
response to the notice.
If you wish to comment in response
to this notice, you may send your
comments to the offices listed under the
ADDRESSES section of this notice. OMB
has up to 60 days to approve or
disapprove the information collection,
but they may respond after 30 days.
Therefore, in order to ensure maximum
consideration, OMB should receive
public comments by November 15,
2012.
Public Comment Policy: We will post
all comments, including names and
addresses of respondents, at
www.regulations.gov. Before including
your address, phone number, e-mail
address, or other personal identifying
information in your comment, you
should be aware that your entire
comment—including your personal
identifying information—may be made
publicly available at any time. While
you can ask us, in your comment, to
withhold your personal identifying
information from public view, we
cannot guarantee that we will be able to
do so.
Information Collection Clearance
Officer: Dave Alspach (202) 219–8526.
Dated: October 2, 2012.
Gregory J. Gould,
Director, Office of Natural Resources
Revenue.
[FR Doc. 2012–25290 Filed 10–15–12; 8:45 am]
tkelley on DSK3SPTVN1PROD with NOTICES
BILLING CODE 4310–T2–C
VerDate Mar<15>2010
16:06 Oct 15, 2012
Jkt 229001
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–857]
Certain Reduced Folate Nutraceutical
Products and L-Methylfolate Raw
Ingredients Used Therein; Institution of
Investigation Pursuant to United States
Code
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that a
complaint was filed with the U.S.
International Trade Commission on
September 10, 2012, under section 337
of the Tariff Act of 1930, as amended,
19 U.S.C. 1337, on behalf of South
Alabama Medical Science Foundation of
Mobile, Alabama; Merck & Cie of
Switzerland; and Pamlab LLC of
Covington, Louisiana. The complaint
alleges violations of section 337 based
upon the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain reduced folate
nutraceutical products and lmethylfolate raw ingredients used
therein by reason of infringement of
certain claims of U.S. Patent No.
5,997,915 (‘‘the ‘915 patent’’); U.S.
Patent No. 6,673,381 (‘‘the ‘381 patent’’);
U.S. Patent No. 7,172,778 (‘‘the ‘778
patent’’); and U.S. Patent No. 6,011,040
(‘‘the ‘040 patent’’). The complaint
further alleges that an industry in the
United States exists as required by
subsection (a)(2) of section 337.
The complainants request that the
Commission institute an investigation
and, after the investigation, issue an
exclusion order and cease and desist
orders.
SUMMARY:
The complaint, except for
any confidential information contained
therein, is available for inspection
during official business hours (8:45 a.m.
to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade
Commission, 500 E Street SW., Room
112, Washington, DC 20436, telephone
(202) 205–2000. Hearing impaired
individuals are advised that information
on this matter can be obtained by
contacting the Commission’s TDD
terminal on (202) 205–1810. Persons
with mobility impairments who will
need special assistance in gaining access
to the Commission should contact the
Office of the Secretary at (202) 205–
2000. General information concerning
the Commission may also be obtained
by accessing its internet server at
https://www.usitc.gov. The public record
for this investigation may be viewed on
ADDRESSES:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
the Commission’s electronic docket
(EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: The
Office of the Secretary, Docket Services
Division, U.S. International Trade
Commission, telephone (202) 205–1802.
Authority: The authority for institution of
this investigation is contained in section 337
of the Tariff Act of 1930, as amended, and
in section 210.10 of the Commission’s Rules
of Practice and Procedure, 19 CFR 210.10
(2012).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
October 10, 2012, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain reduced folate
nutraceutical products and lmethylfolate raw ingredients used
therein that infringe one or more of
claims 37, 39, 40, 47, 66, 67, 73, 76, 78–
81, 83, 84, 86–89, 91, 92, 94–97, 99, 100,
110, 111, 113, 117, and 121 of the ‘915
patent; claims 22, 26, and 32–38 of the
‘381 patent; claims 1, 4–6, and 15 of the
‘778 patent; and claims 1–3, 5, 6, 8, 9,
11–15, and 19–22 of the ‘040 patent, and
whether an industry in the United
States exists as required by subsection
(a)(2) of section 337.
(2) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
South Alabama Medical Science
Foundation, 307 University
Boulevard, PO Box U–1060, Mobile,
AL 36688;
Merck & Cie, Weisshausmatte, 6460
Altdorf, Switzerland;
Pamlab LLC, 4099 Highway 190,
Covington, LA 70433.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Gnosis SpA, Via Lavoratori Autobianchi
1, 20832 Desio (MB), Italy;
Gnosis Bioresearch SA, Via Lischedi, 4,
6592 Sant’Antonino, Switzerland;
Gnosis USA Inc., 160 North Main Street,
Doylestown, PA 18901;
Macoven Pharmaceuticals LLC, 33219
Forest West Street, Magnolia, TX
77354.
(3) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
E:\FR\FM\16OCN1.SGM
16OCN1
Federal Register / Vol. 77, No. 200 / Tuesday, October 16, 2012 / Notices
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in this investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(d)–(e) and 210.13(a),
such responses will be considered by
the Commission if received not later
than 20 days after the date of service by
the Commission of the complaint and
the notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: October 10, 2012.
Lisa R. Barton,
Acting Secretary to the Commission.
BILLING CODE 7020–02–P
JOINT BOARD FOR THE
ENROLLMENT OF ACTUARIES
Renewal of Charter of Advisory
Committee on Actuarial Examinations
Joint Board for the Enrollment
of Actuaries.
ACTION: Notice of Renewal of Advisory
Committee.
AGENCY:
The Joint Board for the
Enrollment of Actuaries announces the
renewal of the charter of the Advisory
Committee on Actuarial Examinations.
FOR FURTHER INFORMATION CONTACT:
Patrick McDonough, 202–622–8225.
SUPPLEMENTARY INFORMATION: The
purpose of the Advisory Committee on
Examinations (Advisory Committee) is
to advise the Joint Board for the
Enrollment of Actuaries (Joint Board) on
tkelley on DSK3SPTVN1PROD with NOTICES
VerDate Mar<15>2010
17:25 Oct 15, 2012
Jkt 229001
Dated: October 9, 2012.
David Ziegler,
Chairman, Joint Board for the Enrollment of
Actuaries.
[FR Doc. 2012–25312 Filed 10–15–12; 8:45 am]
BILLING CODE 4830–01–P
DEPARTMENT OF JUSTICE
[OMB Number 1122–0021]
Agency Information Collection
Activities: Extension of a Currently
Approved Collection; Comments
Requested; Semi-Annual Progress
Report for the Grants To Enhance
Culturally and Linguistically Specific
Services for Victims of Domestic
Violence, Dating Violence, Sexual
Assault, and Stalking
ACTION:
[FR Doc. 2012–25378 Filed 10–15–12; 8:45 am]
SUMMARY:
examinations in actuarial mathematics
and methodology. The Joint Board
administers such examinations in
discharging its statutory mandate to
enroll individuals who wish to perform
actuarial services with respect to
pension plans subject to the Employee
Retirement Income Security Act of 1974.
The Advisory Committee’s functions
include but, are necessarily limited to
(1) considering and recommending
examination topics; (2) developing
examination questions; (3)
recommending proposed examinations
and pass marks; and (4) as requested by
the Joint Board, making
recommendations relative to the
examination program.
30-Day Notice.
The Department of Justice, Office on
Violence Against Women (OVW) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register, Volume 77, Number 157, page
48539 on August 14, 2012, allowing for
a 60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until November 15, 2012. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
63337
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–7285.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection: SemiAnnual Progress Report for Grantees
from Grants to Enhance Culturally and
Linguistically Specific Services for
Victims of Domestic Violence, Dating
Violence, Sexual Assault, and Stalking
Program (Culturally and Linguistically
Specific Services Program).
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: 1122–0021.
U.S. Department of Justice, Office on
Violence Against Women.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract: The affected public includes
the approximately 50 grantees of the
Culturally and Linguistically Specific
Services Program. The program funds
projects that promote the maintenance
and replication of existing successful
domestic violence, dating violence,
sexual assault, and stalking communitybased programs providing culturally
and linguistically specific services and
other resources. The program also
supports the development of innovative
culturally and linguistically specific
E:\FR\FM\16OCN1.SGM
16OCN1
]]>Agencies
[Federal Register Volume 77, Number 200 (Tuesday, October 16, 2012)]
[Notices]
[Pages 63336-63337]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25378]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-857]
Certain Reduced Folate Nutraceutical Products and L-Methylfolate
Raw Ingredients Used Therein; Institution of Investigation Pursuant to
United States Code
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on September 10, 2012, under
section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, on
behalf of South Alabama Medical Science Foundation of Mobile, Alabama;
Merck & Cie of Switzerland; and Pamlab LLC of Covington, Louisiana. The
complaint alleges violations of section 337 based upon the importation
into the United States, the sale for importation, and the sale within
the United States after importation of certain reduced folate
nutraceutical products and l-methylfolate raw ingredients used therein
by reason of infringement of certain claims of U.S. Patent No.
5,997,915 (``the `915 patent''); U.S. Patent No. 6,673,381 (``the `381
patent''); U.S. Patent No. 7,172,778 (``the `778 patent''); and U.S.
Patent No. 6,011,040 (``the `040 patent''). The complaint further
alleges that an industry in the United States exists as required by
subsection (a)(2) of section 337.
The complainants request that the Commission institute an
investigation and, after the investigation, issue an exclusion order
and cease and desist orders.
ADDRESSES: The complaint, except for any confidential information
contained therein, is available for inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S.
International Trade Commission, 500 E Street SW., Room 112, Washington,
DC 20436, telephone (202) 205-2000. Hearing impaired individuals are
advised that information on this matter can be obtained by contacting
the Commission's TDD terminal on (202) 205-1810. Persons with mobility
impairments who will need special assistance in gaining access to the
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be
obtained by accessing its internet server at https://www.usitc.gov. The
public record for this investigation may be viewed on the Commission's
electronic docket (EDIS) at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT: The Office of the Secretary, Docket
Services Division, U.S. International Trade Commission, telephone (202)
205-1802.
Authority: The authority for institution of this investigation
is contained in section 337 of the Tariff Act of 1930, as amended,
and in section 210.10 of the Commission's Rules of Practice and
Procedure, 19 CFR 210.10 (2012).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on October 10, 2012, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain reduced
folate nutraceutical products and l-methylfolate raw ingredients used
therein that infringe one or more of claims 37, 39, 40, 47, 66, 67, 73,
76, 78-81, 83, 84, 86-89, 91, 92, 94-97, 99, 100, 110, 111, 113, 117,
and 121 of the `915 patent; claims 22, 26, and 32-38 of the `381
patent; claims 1, 4-6, and 15 of the `778 patent; and claims 1-3, 5, 6,
8, 9, 11-15, and 19-22 of the `040 patent, and whether an industry in
the United States exists as required by subsection (a)(2) of section
337.
(2) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainants are:
South Alabama Medical Science Foundation, 307 University Boulevard, PO
Box U-1060, Mobile, AL 36688;
Merck & Cie, Weisshausmatte, 6460 Altdorf, Switzerland;
Pamlab LLC, 4099 Highway 190, Covington, LA 70433.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
Gnosis SpA, Via Lavoratori Autobianchi 1, 20832 Desio (MB), Italy;
Gnosis Bioresearch SA, Via Lischedi, 4, 6592 Sant'Antonino,
Switzerland;
Gnosis USA Inc., 160 North Main Street, Doylestown, PA 18901;
Macoven Pharmaceuticals LLC, 33219 Forest West Street, Magnolia, TX
77354.
(3) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission,
[[Page 63337]]
shall designate the presiding Administrative Law Judge.
The Office of Unfair Import Investigations will not participate as
a party in this investigation.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(d)-(e) and 210.13(a), such responses will be
considered by the Commission if received not later than 20 days after
the date of service by the Commission of the complaint and the notice
of investigation. Extensions of time for submitting responses to the
complaint and the notice of investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease and desist order or both directed against the respondent.
By order of the Commission.
Issued: October 10, 2012.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2012-25378 Filed 10-15-12; 8:45 am]
BILLING CODE 7020-02-P
